Skip to main content
. 2018 Aug 28;9(9):849. doi: 10.1038/s41419-018-0877-2

Fig. 6. SOX9 is required for COL10A1-mediated EMT and the aggressive cell phenotype.

Fig. 6

a, b EMT biomarkers (E-cadherin and Vimentin) were detected after transfection of COL10A1-sense plasmids into the indicated cells using western blot analysis and immunofluorescence. c EMT biomarkers were detected after transfection of MKN45 cells with COL10A1-siRNA using western blot analysis. d MMPs (MMP 2, 3, 9, and 14) were detected after transfection of MKN45 cells with COL10A1-siRNA using western blot analysis. e Proteins extracted from AGS cells co-treated with TGF-β1 and the inhibitor SB431542, SOX9 siRNA or COL10A1 siRNA were used to detect EMT markers, phosphorylated Smad2, SOX9 and COL10A1 using western blotting analysis. f Representative figures of transwell assays in AGS cells after treatment with small interfering RNA and/or TGF-β1 are shown. ***P < 0.001. g SOX9, COL10A1, and Ki67 expression levels in peritoneal metastatic specimens were detected using IHC. All results shown were reproduced in at least three independent experiments. Scale bars represent 60 μm in (b, g)